News for 'biotechnology'

Siddaramaiah re-allocates portfolios to Kharge, Patil

Siddaramaiah re-allocates portfolios to Kharge, Patil

Rediff.com31 May 2023

Kharge will take care of IT & BT along with existing portfolio, while Large & Medium Industries Minister M B Patil has been given the additional charge of Infrastructure Development.

AI makes mark in drug discovery in India; start-up Peptris raises $1 mn

AI makes mark in drug discovery in India; start-up Peptris raises $1 mn

Rediff.com21 Dec 2023

The process of discovering and developing a new drug can take decades and costs hundreds of millions or even billions of dollars. However, technological advances like artificial intelligence can help speed up and transform the time-consuming and labor-intensive exercise. In India, Peptris Technologies, a Bangalore-based AI drug discovery company, has announced $1 million in pre-seed round investment led by Speciale Invest.

'I still have feelings for my ex-boyfriend'

'I still have feelings for my ex-boyfriend'

Rediff.com18 Dec 2023

rediffGURU Mohit offers advice on how you can manage your emotions and improve your personality to be more confident and positive.

ISRO, NASA in talks to place Indian on ISS next year

ISRO, NASA in talks to place Indian on ISS next year

Rediff.com8 Sep 2023

India and the US on Friday said they have started talks to put in place a strategic framework for human space flight by year-end as they plan to send an Indian astronaut to the International Space Station in 2024.

10 Foods A Dietician Wants To You To AVOID Eating

10 Foods A Dietician Wants To You To AVOID Eating

Rediff.com31 Jan 2024

Regular consumption of fried, junk and packaged food will have minor to severe health implications, warns dietician Bhakti Adkar.

Karnataka minister alleges Rs 500 cr IT scam under BJP

Karnataka minister alleges Rs 500 cr IT scam under BJP

Rediff.com9 Nov 2023

The IT-BT minister claimed that the then BJP government did not merely charge a '40 per cent commission', as his party had claimed during the assembly election, but had collected a commission of more than 400 per cent.

91 Indian Uni On Times World Rankings

91 Indian Uni On Times World Rankings

Rediff.com28 Sep 2023

India has also become the fourth best represented nation in the 2024 rankings, up from sixth last year.

Why is India's cotton dream turning sour?

Why is India's cotton dream turning sour?

Rediff.com21 Jan 2024

A few days back, Atul Ganatra, president of the Cotton Association of India, presented a grim scenario of the crop's prospects in the 2024-25 season that starts in October. Addressing the association's annual general meeting, Ganatra said the area under the crop could go down by at least 10 per cent in the coming season due to falling yields and realisation, leading to farmers losing interest. The fear of a decline in acreage comes against the backdrop of India's cotton production probably falling to its lowest in a decade, according to estimates.

'I Had 10 Ideas When I Quit My Job'

'I Had 10 Ideas When I Quit My Job'

Rediff.com19 Dec 2023

'When I was toying with 10 different ideas, my father was diagnosed with lung fibrosis and his condition deteriorated so badly that we lost him in six months. He was very unsatisfied with the lack of proper diagnosis.' 'It made me think will anyone do a biopsy if there is no symptom? Why is it that we do not have any non-invasive diagnostic method?' 'This idea was the strongest out of the ten, and with Snahlata Singh with her cancer biology background joining me, the idea got a real boost.'

No threat to Putin's position, Prigozhin wanted to become Prez: Diplomat

No threat to Putin's position, Prigozhin wanted to become Prez: Diplomat

Rediff.com26 Jun 2023

Russia's special presidential representative for international cultural cooperation Mikhail Shvydkoy said Prigozhin wanted to become Russian president but it was a "mistake".

1 more Nipah case found in Kerala, govt to ramp up testing

1 more Nipah case found in Kerala, govt to ramp up testing

Rediff.com15 Sep 2023

A 39-year-old man tested positive for the Nipah virus, which was transmitted to him through direct contact with an infected person who died on August 30, State Health Minister Veena George said in Kozhikode on Friday.

Kharge Jr drags Nadda, Malviya to police over Rahul Gandhi video

Kharge Jr drags Nadda, Malviya to police over Rahul Gandhi video

Rediff.com19 Jun 2023

Karnataka Minister for Information Technology and Biotechnology Priyank Kharge on Monday lodged a complaint against Bharatiya Janata Party national president J P Nadda, BJP's IT cell chief Amit Malviya and BJP Chandigarh president Arun Sood for malicious posts against Rahul Gandhi, particularly an animated video that allegedly features altered versions of the Congress leader's speeches.

K'taka police file FIR against Aaj Tak for 'spreading misinformation'

K'taka police file FIR against Aaj Tak for 'spreading misinformation'

Rediff.com13 Sep 2023

The complainant accused the Consulting Editor of spreading false news about the scheme offered by the corporation and trying to disturb communal harmony in the state.

You can have a career in medicine without giving NEET

You can have a career in medicine without giving NEET

Rediff.com8 Dec 2023

rediffGURU Mayank Chandel offers advice to students interested in a careers in science or engineering after class 10 and 12.

Bio E gets nod for kids' phase 2, 3 Covid vax trial

Bio E gets nod for kids' phase 2, 3 Covid vax trial

Rediff.com3 Sep 2021

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology (DBT) said on Friday.

Covid strain driving China surge also found in India

Covid strain driving China surge also found in India

Rediff.com21 Dec 2022

The first case of BF.7 in India was detected in October by Gujarat Biotechnology Research Centre.

Antidote against Nipah reaches Kerala; expert panel to decide further action

Antidote against Nipah reaches Kerala; expert panel to decide further action

Rediff.com14 Sep 2023

State health minister Veena George said a meeting was held between the principal secretary of the health department and the Union health ministry earlier in the day and now the monoclonal antibody has arrived.

Zydus's India-made Covid vaccine gets emergency use approval

Zydus's India-made Covid vaccine gets emergency use approval

Rediff.com20 Aug 2021

This is the world's first DNA-based vaccine against the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance

Biotechnology sector suffers from talent shortage

Biotechnology sector suffers from talent shortage

Rediff.com11 Apr 2008

The Indian biotech sector continues to face an acute shortage of specialists. But now there is a ray of hope, interestingly from a dark story being narrated in the pharma and biotech sectors in the United States and Europe. The sector is seeing downsizing there. This has made scientists of Indian origin explore opportunities in India. "The shortage and the noticeable gap is in terms of discovery-led drug development," said Kiran Mazumdar Shaw, CMD, Biocon

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

Rediff.com28 Jun 2022

The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.

Roadshow, Gandhi ashram, Akshardham... Boris Johnson has a packed day in Gujarat

Roadshow, Gandhi ashram, Akshardham... Boris Johnson has a packed day in Gujarat

Rediff.com20 Apr 2022

British Prime Minister Boris Johnson will arrive in Ahmedabad on Thursday morning as part of his two-day India visit, and will be accorded a grand welcome on a four-km route from the city airport to a hotel, officials said.

Poonawala's Serum Inst to soon launch India's first cervical cancer vaccine

Poonawala's Serum Inst to soon launch India's first cervical cancer vaccine

Rediff.com1 Sep 2022

India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in an affordable price range of Rs 200-400, Serum Institute of India CEO Adar Poonawalla said on Thursday.

Centre to hold meet amid massive Covid spike in China, elsewhere

Centre to hold meet amid massive Covid spike in China, elsewhere

Rediff.com21 Dec 2022

The minister will review the COVID-19 situation at 11:30 am on Wednesday 'considering the international scenario', they said.

Govt ushers in de-layering in bureaucracy, jt secretary reports to secretary

Govt ushers in de-layering in bureaucracy, jt secretary reports to secretary

Rediff.com29 Mar 2023

The Centre has taken a major step towards increasing efficiency in decision-making by empowering joint secretaries to report to secretaries directly, officials said on Wednesday.

PM-led panel seeks wider panel of names for next AIIMS-Delhi chief: Sources

PM-led panel seeks wider panel of names for next AIIMS-Delhi chief: Sources

Rediff.com21 Jun 2022

The tenure of the incumbent AIIMS director, Dr Randeep Guleria, which was set to end on March 24, was extended by three months.

Nasal Covid Vaccine Available In Jan

Nasal Covid Vaccine Available In Jan

Rediff.com28 Dec 2022

The vaccine would not have production scalability issues unlike Covaxin, Bharat Biotech's COVID-19 virus vaccine.

US scientist who worked at Wuhan lab says Covid was manmade virus

US scientist who worked at Wuhan lab says Covid was manmade virus

Rediff.com5 Dec 2022

In what appears to be an astonishing revelation, a US-based scientist who worked at a controversial research lab in China's Wuhan, has said that Covid-19 was a "man-made virus" that leaked from the facility.

Tech, defence, energy: Key agenda for Modi-Biden talks

Tech, defence, energy: Key agenda for Modi-Biden talks

Rediff.com17 Jun 2023

Modi will arrive in New York on June 20 and will lead the 9th International Yoga Day celebrations at the UN headquarters on June 21.

India's first mRNA vaccine gets nod for human trials

India's first mRNA vaccine gets nod for human trials

Rediff.com12 Dec 2020

The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the conventional model to produce immune response. Instead, they carry molecular instructions to make the protein in the body through a synthetic RNA of the virus.

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Rediff.com15 Aug 2022

The company said it had conducted two separate trials for its intranasal Covid vaccine, one as a primary dose schedule and another as a booster dose, for subjects who have been double vaccinated with the two commonly administered Covid vaccines in India.

Bharat Biotech making single-dose intranasal Covid vaccine

Bharat Biotech making single-dose intranasal Covid vaccine

Rediff.com21 Apr 2021

Efforts are being ramped up for massive production of vaccines and make them available in the shortest possible time, a top government official said on Wednesday, stressing that India currently has a promising pipeline of four-five Covid-19 vaccine candidates, while three have already been approved for emergency use.

Several JNU, IIT professors duped of crores by ex-staffer

Several JNU, IIT professors duped of crores by ex-staffer

Rediff.com7 Jan 2023

Several professors of Jawaharlal Nehru University and other institutions have accused a former JNU employee of duping them of crores of rupees promising them homes on a Delhi Development Authority (DDA) plot under a housing development scheme which was never there.

FM announces Rs 900 cr for COVID-19 vaccine research

FM announces Rs 900 cr for COVID-19 vaccine research

Rediff.com12 Nov 2020

She said the grant does not cover the actual cost of vaccine and distribution expenses, which will be made separately as and when the vaccine is available.

Centre advises use of mask in crowded areas amid fresh Covid scare

Centre advises use of mask in crowded areas amid fresh Covid scare

Rediff.com21 Dec 2022

He urged people not to panic and clarified that there was no change in the guidelines for international air travel so far.

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

GEAC clears environmental release of GM mustard

GEAC clears environmental release of GM mustard

Rediff.com27 Oct 2022

The Genetic Engineering Appraisal Committee (GEAC) has recommended the environmental release of the genetically modified (GM) mustard variety DMH (Dhara Mustard Hybrid)-11, paving the way for the commercialisation of the country's first GM food crop. The GEAC said the recommendation was valid for four years from the date the approval letter was issued. Further studies and coordinated trials will have to be conducted jointly with the Indian Council of Agriculture Research (ICAR) within two years, according to the minutes of the GEAC meeting held on October 18, which was released on Wednesday.

Covid: Omicron, sub-lineages dominant variant in India

Covid: Omicron, sub-lineages dominant variant in India

Rediff.com6 Aug 2022

"The COVID-19 cases are rising, but hospitalization and deaths are still less," said sources.

Why's There Turmoil In The Start-Up World?

Why's There Turmoil In The Start-Up World?

Rediff.com12 Jan 2023

The turmoil, if you read the headlines, is about the so-called funding winter. Deep down, though, the question is one of the common direction in which founders and investors need to pull, points out Suveen Sinha.

US House recommends CAATSA waiver for India

US House recommends CAATSA waiver for India

Rediff.com15 Jul 2022

The legislative amendment was passed on Thursday by voice vote as part of an en bloc (all together as a single unit) amendment during floor consideration of the National Defence Authorisation Act (NDAA).

100 million Covaxin vaccines by Sept

100 million Covaxin vaccines by Sept

Rediff.com17 Apr 2021

The production of Covaxin will increase from the current 10 million doses per month to 60 million-70 million by July-August.